Tannic Acid preferentially targets estrogen receptor-positive breast cancer

Brian W Booth1, Beau D Inskeep2, Hiral Shah2

  • 1Institute for Biological Interfaces of Engineering, Clemson University, Clemson, SC 29634, USA.

Insights

Tannic acid (TA), a natural compound, was used to create collagen beads that inhibited cancer cell growth and induced apoptosis. Estrogen receptor-positive breast cancer cells were particularly sensitive to TA, suggesting its potential as a preventative or treatment agent.

Area of Science:

  • Biochemistry
  • Oncology
  • Natural Products Chemistry

Background:

  • Natural compounds are increasingly explored for cancer treatment.
  • Tannic acid (TA) is a hydrolysable tannin found in plants and foods.
  • TA is known for its collagen cross-linking properties.

Purpose of the Study:

  • To create tannic acid-cross-linked collagen beads.
  • To evaluate the impact of these beads on breast cancer cell proliferation and apoptosis.
  • To investigate the specific mechanisms of TA-induced cell death.

Main Methods:

  • Preparation of collagen beads cross-linked with varying concentrations of tannic acid.
  • Assessment of bead stability at body temperature.
  • Exposure of normal and breast cancer cells to TA-cross-linked beads.
  • Analysis of cell proliferation, apoptosis markers (caspase 3/7, 9, and 8), and estrogen receptor (ER) status.

Main Results:

  • TA-cross-linked collagen beads were stable at body temperature.
  • Higher concentrations of TA significantly inhibited cell proliferation and induced apoptosis in both normal and cancer cells.
  • TA-induced apoptosis was mediated by the activation of caspase 3/7 and caspase 9.
  • Estrogen receptor-positive (ER(+)) breast cancer cells showed increased susceptibility to TA's effects.

Conclusions:

  • Tannic acid-cross-linked collagen beads demonstrate anti-cancer properties.
  • TA induces apoptosis through the intrinsic caspase pathway.
  • TA shows particular efficacy against ER(+) breast cancer cells.
  • Tannic acid holds potential as a therapeutic or preventative agent for ER(+) breast cancer.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
598
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K